GlassScriptPhysician profile
Angela Li
NPI 1235510173
$8,116.95
in general payments reported to CMS, 2019-2025
13 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what 89% of Adult Congenital Heart Disease providers received nationally (typical 2025 total: $272).
See the full distribution for Adult Congenital Heart Disease
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $230 · 2021: $146 · 2022: $2,603 · 2023: $1,582 · 2024: $815 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,500 · Food and Beverage: $2,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,500.36 |
| Food and Beverage | $2,432.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,141.06 | 2022-2025 | Amplatzer Piccolo, Optis, Amplatzer |
| Medtronic, INC. | $2,332.35 | 2022-2024 | Harmony, Symplicity G3, Acist Rxi System |
| Astrazeneca Pharmaceuticals LP | $283.27 | 2019-2022 | |
| Shockwave Medical, INC | $282.34 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $176.00 | 2020 | |
| Abiomed | $150.98 | 2025 | |
| Janssen Pharmaceuticals, INC | $145.50 | 2021 | |
| Edwards Lifesciences Corporation | $123.44 | 2022 | |
| Medtronic Vascular, INC. | $102.90 | 2019 | |
| Genzyme Corporation | $95.26 | 2024 | |
| Chiesi USA, INC. | $75.13 | 2022 | |
| Esperion Therapeutics, INC. | $26.73 | 2025 | Nexletol |
| W. L. Gore & Associates, INC. | $16.83 | 2024 | Gore Cardioform Septal Occluder |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.